As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation ...

Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.

Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer treatment responses in individual cells – without the need for dyes or labels.

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.